Page 11 - Pharmaceutical

Regulatory woes resurface for Indian pharma companies as stocks fall

Concerns over US sales are diluting positives of strong domestic growth, and have led to a 10 per cent fall in the Nifty Pharma index in one month

Net practice for healing: Netmeds unveils brand campaign with MS Dhoni

That the app was noted, and was able to hit the right chord was evident from the two million downloads that it received from the day it was launched

Global pharmaceutical packaging market to reach $ 158 billion by 2025

Emerging economies such as India, China, Brazil, etc to drive this growth, says Grand View Research

Intrexon & Johnson Matthey team up for production of peptide-based APIs

Though peptide-based APIs are highly useful, they are often costly & difficult to produce

Soon, Jan Aushadhi stores to open at railway stations

Govt plans to utilise railway's infrastructure to increase accessibility of affordable generic drugs

Italian firm Olon buys Ricerca Biosciences' chemical division

Acquisition strengthens service offering of Olon SpA for research and manufacturing

Unichem Laboratories aims $ 100 mn revenue from US

For this, the company will focus on differentiated complex generics, which are difficult to produce

JSR Corp arm KBI Biopharma to invest $ 30 mn to expand two facilities in US

It will expand biopharmaceutical manufacturing capacity at both its Durham and Boulder facilities

Bal Pharma to close down parenterals & IV fluids facility at Pune

Decision was taken as part of its restructuring exercise undertaken to streamline its operations

Pharmaceutical packaging equipment market to reach $ 8.24 billion by 2022

Need for stringent regulatory compliances is driving this market, says MarketsandMarkets report

Alivira's animal health API facility gets US FDA approval

Approval will enable SeQuent Scientific arm to enter the $ 8-bn US veterinary healthcare market

Govt's aim is to make IPR policy more efficient: Nirmala Sitharaman

India's IPR policy is TRIPS compliant and forward looking, says the Minister of Commerce & Industry

Glenmark starts clinical trial for biosimilar used to treat allergic asthma

The reference product for this biosimilar is omalizumab, sold under the brand name Xolair

Amgen & Novartis expand collaboration for migraine drug Erenumab

It builds on their global neuroscience partnership in Alzheimer's disease & migraine formed in 2015

Merck sells biosimilars business to Fresenius to focus on innovative drugs

Merck to receive upfront payment of € 170 mn & milestone payments of up to € 500 mn on future sales

US FDA issues warning letter for Divi's Laboratories' Visakhapatnam unit

Last month, US drug regulator had issued an import alert on the products manufactured from this unit

Avantor Performance Materials acquires Puritan Products

Deal to enhance Avantor's portfolio of high-purity cGMP materials & solutions for biopharma industry

Sawai Pharmaceutical buys Upsher?Smith's generics business for $1.05 bn

The acquisition will mark a major expansion of Sawai's presence in the US market

BioInvent to use Merck's bioreactors to expand Swiss facility

Addition of single-use Mobius bioreactors to streamline BioInvent's drug development & production

Bain Capital & Cinven buy German generic drug maker Strada for € 4.1 bn

Stada offers a portfolio of high-quality, low-cost generic products including selected biosimilars